Alkermes plc. Operating Leases, Rent Expense, Sublease Rentals
Alkermes plc. (ALKS) reported Operating Leases, Rent Expense, Sublease Rentals of $700.00 thousand for the 12-month period ending 2015-12-31, per its 10-K filed 2018-02-16.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingLeasesRentExpenseSubleaseRentals1 · last filed 2018-02-16
- Alkermes plc. operating leases, rent expense, sublease rentals for fiscal 2015 was $700.00K, a 0.00% change from fiscal 2014.
- Alkermes plc. operating leases, rent expense, sublease rentals for fiscal 2014 was $700.00K.
- Alkermes plc. operating leases, rent expense, sublease rentals for fiscal 2013 was $2.60M, a 71.74% decline from fiscal 2012.
- Alkermes plc. operating leases, rent expense, sublease rentals for fiscal 2012 was $9.20M, a 26.03% increase from fiscal 2011.
| Period end | Operating Leases, Rent Expense, Sublease Rentals 9 month | Operating Leases, Rent Expense, Sublease Rentals 12 month |
|---|---|---|
| 2015-12-31 | $700.00K 10-K · filed 2018-02-16 | |
| 2014-12-31 | $700.00K 10-K · filed 2017-02-17 | |
| 2013-12-31 | $700.00K 10-K · filed 2015-02-24 | |
| 2013-03-31 | $2.60M 10-K · filed 2015-02-24 | |
| 2012-03-31 | $9.20M 10-KT · filed 2014-02-27 | |
| 2011-03-31 | $7.30M 10-K · filed 2013-05-23 | |
| 2010-03-31 | $3.50M 10-K · filed 2012-05-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |